ACC 2014 schedule: Difference between revisions
Created page with "Here is the page we will use to coordinate the TV events at ACC 2014. Open time slots are indicated below in red. Filming location TBD. ---- __NOTOC__ ==Click on Date for D..." |
|||
(70 intermediate revisions by the same user not shown) | |||
Line 19: | Line 19: | ||
==Saturday, March 29, 2014== | ==Saturday, March 29, 2014== | ||
===10:00 AM=== | ===10:00 AM=== | ||
''10:00AM - 10:30AM'' | |||
*'''Interviewee:''' Dr. P.J. Devereaux | |||
*'''Topic:''' The Impact of Acetyl-Salicylic Acid on Major Arterial and Venous Complications in Patients Undergoing Noncardiac Surgery | |||
*'''Embargo Lift:''' Monday, March 31, 2014 at 8:00am | |||
===10:30 AM=== | ===10:30 AM=== | ||
''10:30 AM - 11:00AM'' | |||
*'''Interview:''' Dr. Nadia Bandstein | |||
*'''Topic:''' Negative High-Sensitive Troponins in the Emergency Department and Risk of Myocardial Infarction | |||
*'''Embargo lift:''' Sunday, March 30, 2014 at 11:45am | |||
=== | ===2:00 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
===2:30 PM=== | ===2:30 PM=== | ||
''2:30 PM - 3:00 PM'' | |||
*'''Interviewee:'''Dr. Jennifer Robinson | |||
*'''Topic:''' The Low-density Lipoprotein Cholesterol Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy - 2 Trial: A Phase 3, Double-blind, Randomized, Placebo and Ezetimibe Controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Combination With Statin Therapy in Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia | |||
*'''Embargo Lift:''' Sunday, March 30, 2014 at 8:15am | |||
===3:00 PM=== | ===3:00 PM=== | ||
''3:00 PM - 3:30 PM'' | ''3:00 PM - 3:30 PM'' | ||
*'''Interview:''' Dr. Marco Valgimigli | *'''Interview:''' Dr. Marco Valgimigli | ||
*'''Topic:''' | *'''Topic:''' Bare Metal vs. Zotarolimus-eluting stent in Uncertain Drug-eluting Stent Candidates: A Randomized Controlled Trial | ||
*'''Embargo lift:''' Monday, March 31, 2014 at 11:30 AM | *'''Embargo lift:''' Monday, March 31, 2014 at 11:30 AM | ||
===3:30 PM=== | ===3:30 PM=== | ||
''3:30 PM - 4:00 PM'' | |||
*'''Interview:''' Dr. A. Michael Lincoff | *'''Interview:''' Dr. A. Michael Lincoff | ||
*'''Topic:''' | *'''Topic:''' Evaluation of the Dual PPAR-α/γ Agonist Aleglitazar to Reduce Cardiovascular Events in Patients with Acute Coronary Syndrome and Type 2 Diabetes Mellitus: the AleCardio Trial | ||
*'''Embargo lift:''' Monday, March 31, 2014 at 11:30 AM | *'''Embargo lift:''' Monday, March 31, 2014 at 11:30 AM | ||
===4:00 PM=== | ===4:00 PM=== | ||
''4:00 PM - 4 | ''4:00 PM - 4:15 PM'' | ||
*'''Interviewee:''' Dr. Ajay Kirtane | |||
*'''Topic:''' Daily ACC Wrap-up in English | |||
*'''Interviewee:''' Dr. | |||
*'''Topic:''' | |||
== Sunday, March 30, 2014== | == Sunday, March 30, 2014== | ||
===9:00 AM=== | ===9:00 AM=== | ||
''9:00 AM | ''9:00 AM - 9:30AM'' | ||
'''*TCTMD Studio Not Available''' | |||
*''' | |||
===9:30 AM=== | ===9:30 AM=== | ||
''9:30 AM - 10:30AM'' | |||
'''*TCTMD Studio Not Available''' | |||
===10:00 AM=== | ===10:00 AM=== | ||
''10:00 AM - 10:30AM'' | |||
'''*TCTMD Studio Not Available''' | |||
===10:30 AM=== | ===10:30 AM=== | ||
''10:30 AM - 11: | ''10:30 AM - 11:30AM'' | ||
'''*TCTMD Studio Not Available''' | |||
*''' | |||
===11:00 AM=== | ===11:00 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===11:30 AM=== | ===11:30 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
===12:00 PM=== | |||
''12:00 PM - 12:30 PM'' | |||
<font color=red>OPEN TIME SLOT</font> | |||
===12:30 PM=== | |||
''12:30 PM - 1:00 PM'' | |||
*'''Interviewee:''' Dr. Masahiro Natsuaki | |||
*'''Topic:''' Two-year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer: the NOBORITM Biolimus-Eluting versus XIENCETM/PROMUSTM Everolimus-eluting Stent Trial (NEXT) | |||
*'''Embargo Lift:''' Sunday, March 30, 2014 at 8:45am | |||
===1:00 PM=== | ===1:00 PM=== | ||
''1:00 PM - 1:30 PM'' | |||
*'''Interview:''' Dr. Anders Bruun Mathiasen and Professor Jens Kastrup | |||
*'''Topic:''' Autotransplantation of Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Severe Ischemic Heart Failure: The MSC-HF Trial | |||
*'''Embargo lift:''' Monday, March 31, 2014 at 11:45am | |||
===1:30 PM=== | ===1:30 PM=== | ||
''1:30 PM - 2:00 PM'' | |||
*'''Interviewee:''' Dr. Rogerio Sarmentio-Leite | |||
*'''Topic:''' ACC Wrap-up in Portuguese | |||
===2:00 PM=== | ===2:00 PM=== | ||
''2: | ''2:00PM - 2:30 PM'' | ||
*'''Interviewee:''' Dr. Basil Lewis | *'''Interviewee:''' Dr. Basil Lewis | ||
*'''Topic:''' | *'''Topic:''' ACC Wrap-up in Hebrew | ||
===2:30 PM=== | ===2:30 PM=== | ||
''2:30 PM - 3:00 PM'' | ''2:30 PM - 3:00 PM'' | ||
*''' | *'''Interview:'''Dr. Ilan Goldenberg | ||
*'''Topic:''' | *'''Topic:''' Long-term Survival with Cardiac Resynchronization Therapy in Patients with Mild Heart Failure | ||
*'''Embargo lift:''' | *'''Embargo lift:''' Sunday, March 30, 2014 at 11:45 AM | ||
===3:00 PM=== | ===3:00 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===3:30 PM=== | ===3:30 PM=== | ||
''3:30 PM - 4:00 PM'' | ''3:30 PM - 4:00 PM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Roxana Mehran | ||
*'''Topic:''' | *'''Topic:''' ACC Wrap-up in English | ||
===4:00 PM=== | ===4:00 PM=== | ||
''4:00 PM - 4:30 PM'' | |||
*'''Interviewee:''' Dr. Ajay Kirtane | |||
*'''Topic:''' ACC Wrap-up in English | |||
===4:30 PM=== | ===4:30 PM=== | ||
''4:30 PM - 5:00PM'' | |||
'''*TCTMD Studio Not Available''' | |||
===5:00PM=== | |||
''5:00 PM - 5:30 PM'' | |||
'''*TCTMD Studio Not Available''' | |||
===5:30PM=== | |||
''5:30PM - 6:00 PM'' | |||
'''*TCTMD Studio Not Available''' | |||
===6:00PM=== | |||
''6:00 PM - 6:30 PM'' | |||
'''*TCTMD Studio Not Available''' | |||
==Monday, March 31, 2014== | ==Monday, March 31, 2014== | ||
===8:00 AM=== | ===8:00 AM=== | ||
''8:00AM - 8:30AM'' | |||
*'''Interviewee:''' Dr. Deepak Bhatt | |||
*'''Topic:''' The Main Results of SYMPLICITY HTN-3 | |||
*'''Embargo Lift:''' Saturday, March 29, 2014 at 9:35am | |||
===8:30 AM=== | ===8:30 AM=== | ||
''8: | ''8:30AM - 9:00AM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Stefan James | ||
*'''Topic:''' | *'''Topic:''' ACC Wrap-up from the Scandinavian Perspective | ||
===9:00 AM=== | ===9:00 AM=== | ||
''9:00 AM - 9:30 AM'' | |||
*'''Interviewee:''' Dr. David Adams | |||
*'''Topic:''' A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed High-Risk for Surgery | |||
*'''Embargo Lift:''' Saturday, March 29, 2014 at 9:10am | |||
===9:30 AM=== | ===9:30 AM=== | ||
Line 165: | Line 166: | ||
===10:00 AM=== | ===10:00 AM=== | ||
''10:00 AM | ''10:00 AM - 10:30 AM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Massimo Imazio | ||
*'''Topic:''' | *'''Topic:''' Efficacy And Safety Of Colchicine In Patients With Multiple Recurrences Of Pericarditis: Results Of A Multicenter, Double-blind, Placebo-controlled, Randomized Study (corp-2 Trial) | ||
*'''Embargo Lift:''' Sunday, March 30, 2014 at 10:45am | |||
===10:30 AM=== | ===10:30 AM=== | ||
''10:30 AM - 11:00AM'' | |||
*'''Interviewee:''' Dr. Aimee Armstrong | |||
*'''Topic:''' One Year Follow-up of the Melody Transcatheter Pulmonary Valve Multicenter Post Approval Study | |||
*'''Embargo Lift:''' Sunday, March 30, 2014 at 11:15am | |||
===11:00 AM=== | ===11:00 AM=== | ||
''11:00AM - 11:30AM'' | |||
*'''Interviewee:''' Dr. Phillip Raymond Schauer | |||
*'''Topic:''' Effect of Bariatric Surgery vs. Intensive Medical Therapy on Long-term Glycemic Control and Complications of Diabetes: 3-Year STAMPEDE Trial Results | |||
*'''Embargo Lift:''' Monday, March 31, 2014 at 9:00am | |||
===11:30 AM=== | ===11:30 AM=== | ||
''11:30AM - 12:00PM'' | |||
*'''Interviewee:''' Dr. Ajay Kirtane | |||
*'''Topic:''' ACC Wrap-up in English | |||
===12:00 PM=== | |||
''12:00 PM - 12:30 PM'' | |||
*'''Interviewee:''' Dr. Hisao Ogawa and Dr. Tomohiro Sakamoto | |||
*'''Topic:''' ACC Wrap-up in Japanese | |||
===12:30 PM=== | |||
''12:30 PM - 1:00 PM'' '''*TCTMD Webcast - Studio Not Available''' | |||
*'''Interviewee:''' Dr. Richard Whitlock | |||
*'''Topic:''' Steroids in Cardiac Surgery (SIRS) | |||
*'''Embargo Lift:''' Monday, March 31, 2014 at 8:30am | |||
===1:00 PM=== | ===1:00 PM=== | ||
''1:00 PM - 1:30 PM'' '''*TCTMD Webcast - Studio Not Available''' | |||
*'''Interviewee:''' Dr. Gennaro Sardella | |||
*'''Topic:''' ACC Wrap-up in Italian | |||
===1:30 PM=== | ===1:30 PM=== | ||
''1:30 PM - 2:00 PM'' '''*TCTMD Webcast - Studio Not Available''' | |||
*'''Interviewee:''' Dr. Daniel Sessler | |||
*'''Topic:''' A Large International Trial Assessing the Effects of Clonidine on Major Arterial Events in Patients Having Noncardiac Surgery | |||
*'''Embargo Lift:''' Monday, March 31, 2014 at 8:15am | |||
===2:00 PM=== | ===2:00 PM=== | ||
''2:00 PM – 2:30 PM'' | ''2:00 PM – 2:30 PM'' '''*TCTMD Webcast -Studio Not Available''' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Juan Gaspar | ||
*'''Topic:''' | *'''Topic:''' ACC Wrap-Up in Spanish | ||
===2:30 PM=== | ===2:30 PM=== | ||
''2:30 PM – 3:00 PM'' | ''2:30 PM – 3:00 PM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Freek Verheugt | ||
*'''Topic:''' | *'''Topic:''' ACC Wrap-Up in Dutch | ||
===3:00 PM=== | ===3:00 PM=== | ||
''3:00 PM | ''3:00 PM - 3:30 PM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Mohamed Abdel-Wahab | ||
*'''Topic:''' | *'''Topic:'''A Randomized Comparison of Self-Expandable and Balloon-Expandable Prostheses in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement - The CHOICE Trial | ||
*'''Embargo Lift:''' Sunday, March 30, 2014 at 8:00am | |||
===3:30 PM=== | ===3:30 PM=== | ||
''3:30 PM - 4:00 PM'' | |||
*'''Interviewee:''' Dr. Gilles Montalescot | |||
*'''Topic:''' ACC Wrap-up in French | |||
===4:00 PM=== | ===4:00 PM=== | ||
''4:00 PM - 4:30 PM'' | |||
*'''Interviewee:''' Dr. David Holmes | |||
*'''Topic:''' One Year Outcomes from the STS/ACC Transcatheter Valve Therapy (TVT) Registry | |||
*'''Embargo Lift:''' Monday, March 31, 2014 at 10:45am | |||
===4:30 PM=== | ===4:30 PM=== | ||
''4: | ''4:30PM - 5:00PM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Chris Lexis | ||
*'''Topic:''' | *'''Topic:''' Metformin in Acute Myocardial Infarction | ||
*'''Embargo Lift:''' Monday, March 31, 2014 at 8:45am | |||
===5:00 PM=== | |||
''5:00 PM - 5:20 PM'' | |||
*'''Interviewee:''' Dr. Adeel Shahzad and Dr. Rod Stables (PI on Study) | |||
*'''Topic:''' Unfractionated Heparin versus Bivalirudin in Primary Percutaneous Coronary Intervention: A Unique Randomized Controlled Trial with Consecutive, Unselected Patient Enrollment (using Delayed Consent), Designed to Reflect Real-World, Contemporary Practice | |||
*'''Embargo Lift:''' Monday, March 31, 2014 at 12:30pm | |||
===5:20 PM=== | |||
''5:20 PM - 5:40 PM'' | |||
*'''Interviewee:''' Professor Harvey White | |||
*'''Topic:''' Effect of Inhibition of Lipoprotein-Associated Phospholipase A2 with Darapladib on Ischemic Events in Patients with Chronic Coronary Heart Disease: The STABILITY (STabilisation of Atherosclerotic plaque By Initiation of darapLadIb TherapY) Trial '''and''' ACC Wrap-up from the Pacific Rim Perspective | |||
*'''Embargo Lift:''' Sunday, March 30, 2014 at 8:00am | |||
==Tuesday, April 1, 2014== | ==Tuesday, April 1, 2014== | ||
===8:00 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===8:30 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===9:00 AM=== | ===9:00 AM=== | ||
''9:00 AM - 9:30 AM'' | ''9:00 AM - 9:30 AM'' *'''TCTMD Studio Not Available''' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Sigmund Silber | ||
*'''Topic:''' | *'''Topic:''' ACC Wrap Up in German | ||
===9:30 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===10:00 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===10:30 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===11:00 AM=== | ===11:00 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===11:30 AM=== | |||
<font color=red>OPEN TIME SLOT</font> |
Latest revision as of 17:00, 27 March 2014
Here is the page we will use to coordinate the TV events at ACC 2014. Open time slots are indicated below in red.
Filming location TBD.
Click on Date for Detailed Schedule
Saturday, March 29, 2014
10:00 AM
10:00AM - 10:30AM
- Interviewee: Dr. P.J. Devereaux
- Topic: The Impact of Acetyl-Salicylic Acid on Major Arterial and Venous Complications in Patients Undergoing Noncardiac Surgery
- Embargo Lift: Monday, March 31, 2014 at 8:00am
10:30 AM
10:30 AM - 11:00AM
- Interview: Dr. Nadia Bandstein
- Topic: Negative High-Sensitive Troponins in the Emergency Department and Risk of Myocardial Infarction
- Embargo lift: Sunday, March 30, 2014 at 11:45am
2:00 PM
OPEN TIME SLOT
2:30 PM
2:30 PM - 3:00 PM
- Interviewee:Dr. Jennifer Robinson
- Topic: The Low-density Lipoprotein Cholesterol Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy - 2 Trial: A Phase 3, Double-blind, Randomized, Placebo and Ezetimibe Controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Combination With Statin Therapy in Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia
- Embargo Lift: Sunday, March 30, 2014 at 8:15am
3:00 PM
3:00 PM - 3:30 PM
- Interview: Dr. Marco Valgimigli
- Topic: Bare Metal vs. Zotarolimus-eluting stent in Uncertain Drug-eluting Stent Candidates: A Randomized Controlled Trial
- Embargo lift: Monday, March 31, 2014 at 11:30 AM
3:30 PM
3:30 PM - 4:00 PM
- Interview: Dr. A. Michael Lincoff
- Topic: Evaluation of the Dual PPAR-α/γ Agonist Aleglitazar to Reduce Cardiovascular Events in Patients with Acute Coronary Syndrome and Type 2 Diabetes Mellitus: the AleCardio Trial
- Embargo lift: Monday, March 31, 2014 at 11:30 AM
4:00 PM
4:00 PM - 4:15 PM
- Interviewee: Dr. Ajay Kirtane
- Topic: Daily ACC Wrap-up in English
Sunday, March 30, 2014
9:00 AM
9:00 AM - 9:30AM *TCTMD Studio Not Available
9:30 AM
9:30 AM - 10:30AM *TCTMD Studio Not Available
10:00 AM
10:00 AM - 10:30AM *TCTMD Studio Not Available
10:30 AM
10:30 AM - 11:30AM *TCTMD Studio Not Available
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
12:00 PM
12:00 PM - 12:30 PM OPEN TIME SLOT
12:30 PM
12:30 PM - 1:00 PM
- Interviewee: Dr. Masahiro Natsuaki
- Topic: Two-year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer: the NOBORITM Biolimus-Eluting versus XIENCETM/PROMUSTM Everolimus-eluting Stent Trial (NEXT)
- Embargo Lift: Sunday, March 30, 2014 at 8:45am
1:00 PM
1:00 PM - 1:30 PM
- Interview: Dr. Anders Bruun Mathiasen and Professor Jens Kastrup
- Topic: Autotransplantation of Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Severe Ischemic Heart Failure: The MSC-HF Trial
- Embargo lift: Monday, March 31, 2014 at 11:45am
1:30 PM
1:30 PM - 2:00 PM
- Interviewee: Dr. Rogerio Sarmentio-Leite
- Topic: ACC Wrap-up in Portuguese
2:00 PM
2:00PM - 2:30 PM
- Interviewee: Dr. Basil Lewis
- Topic: ACC Wrap-up in Hebrew
2:30 PM
2:30 PM - 3:00 PM
- Interview:Dr. Ilan Goldenberg
- Topic: Long-term Survival with Cardiac Resynchronization Therapy in Patients with Mild Heart Failure
- Embargo lift: Sunday, March 30, 2014 at 11:45 AM
3:00 PM
OPEN TIME SLOT
3:30 PM
3:30 PM - 4:00 PM
- Interviewee: Dr. Roxana Mehran
- Topic: ACC Wrap-up in English
4:00 PM
4:00 PM - 4:30 PM
- Interviewee: Dr. Ajay Kirtane
- Topic: ACC Wrap-up in English
4:30 PM
4:30 PM - 5:00PM *TCTMD Studio Not Available
5:00PM
5:00 PM - 5:30 PM *TCTMD Studio Not Available
5:30PM
5:30PM - 6:00 PM *TCTMD Studio Not Available
6:00PM
6:00 PM - 6:30 PM *TCTMD Studio Not Available
Monday, March 31, 2014
8:00 AM
8:00AM - 8:30AM
- Interviewee: Dr. Deepak Bhatt
- Topic: The Main Results of SYMPLICITY HTN-3
- Embargo Lift: Saturday, March 29, 2014 at 9:35am
8:30 AM
8:30AM - 9:00AM
- Interviewee: Dr. Stefan James
- Topic: ACC Wrap-up from the Scandinavian Perspective
9:00 AM
9:00 AM - 9:30 AM
- Interviewee: Dr. David Adams
- Topic: A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed High-Risk for Surgery
- Embargo Lift: Saturday, March 29, 2014 at 9:10am
9:30 AM
OPEN TIME SLOT
10:00 AM
10:00 AM - 10:30 AM
- Interviewee: Dr. Massimo Imazio
- Topic: Efficacy And Safety Of Colchicine In Patients With Multiple Recurrences Of Pericarditis: Results Of A Multicenter, Double-blind, Placebo-controlled, Randomized Study (corp-2 Trial)
- Embargo Lift: Sunday, March 30, 2014 at 10:45am
10:30 AM
10:30 AM - 11:00AM
- Interviewee: Dr. Aimee Armstrong
- Topic: One Year Follow-up of the Melody Transcatheter Pulmonary Valve Multicenter Post Approval Study
- Embargo Lift: Sunday, March 30, 2014 at 11:15am
11:00 AM
11:00AM - 11:30AM
- Interviewee: Dr. Phillip Raymond Schauer
- Topic: Effect of Bariatric Surgery vs. Intensive Medical Therapy on Long-term Glycemic Control and Complications of Diabetes: 3-Year STAMPEDE Trial Results
- Embargo Lift: Monday, March 31, 2014 at 9:00am
11:30 AM
11:30AM - 12:00PM
- Interviewee: Dr. Ajay Kirtane
- Topic: ACC Wrap-up in English
12:00 PM
12:00 PM - 12:30 PM
- Interviewee: Dr. Hisao Ogawa and Dr. Tomohiro Sakamoto
- Topic: ACC Wrap-up in Japanese
12:30 PM
12:30 PM - 1:00 PM *TCTMD Webcast - Studio Not Available
- Interviewee: Dr. Richard Whitlock
- Topic: Steroids in Cardiac Surgery (SIRS)
- Embargo Lift: Monday, March 31, 2014 at 8:30am
1:00 PM
1:00 PM - 1:30 PM *TCTMD Webcast - Studio Not Available
- Interviewee: Dr. Gennaro Sardella
- Topic: ACC Wrap-up in Italian
1:30 PM
1:30 PM - 2:00 PM *TCTMD Webcast - Studio Not Available
- Interviewee: Dr. Daniel Sessler
- Topic: A Large International Trial Assessing the Effects of Clonidine on Major Arterial Events in Patients Having Noncardiac Surgery
- Embargo Lift: Monday, March 31, 2014 at 8:15am
2:00 PM
2:00 PM – 2:30 PM *TCTMD Webcast -Studio Not Available
- Interviewee: Dr. Juan Gaspar
- Topic: ACC Wrap-Up in Spanish
2:30 PM
2:30 PM – 3:00 PM
- Interviewee: Dr. Freek Verheugt
- Topic: ACC Wrap-Up in Dutch
3:00 PM
3:00 PM - 3:30 PM
- Interviewee: Dr. Mohamed Abdel-Wahab
- Topic:A Randomized Comparison of Self-Expandable and Balloon-Expandable Prostheses in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement - The CHOICE Trial
- Embargo Lift: Sunday, March 30, 2014 at 8:00am
3:30 PM
3:30 PM - 4:00 PM
- Interviewee: Dr. Gilles Montalescot
- Topic: ACC Wrap-up in French
4:00 PM
4:00 PM - 4:30 PM
- Interviewee: Dr. David Holmes
- Topic: One Year Outcomes from the STS/ACC Transcatheter Valve Therapy (TVT) Registry
- Embargo Lift: Monday, March 31, 2014 at 10:45am
4:30 PM
4:30PM - 5:00PM
- Interviewee: Dr. Chris Lexis
- Topic: Metformin in Acute Myocardial Infarction
- Embargo Lift: Monday, March 31, 2014 at 8:45am
5:00 PM
5:00 PM - 5:20 PM
- Interviewee: Dr. Adeel Shahzad and Dr. Rod Stables (PI on Study)
- Topic: Unfractionated Heparin versus Bivalirudin in Primary Percutaneous Coronary Intervention: A Unique Randomized Controlled Trial with Consecutive, Unselected Patient Enrollment (using Delayed Consent), Designed to Reflect Real-World, Contemporary Practice
- Embargo Lift: Monday, March 31, 2014 at 12:30pm
5:20 PM
5:20 PM - 5:40 PM
- Interviewee: Professor Harvey White
- Topic: Effect of Inhibition of Lipoprotein-Associated Phospholipase A2 with Darapladib on Ischemic Events in Patients with Chronic Coronary Heart Disease: The STABILITY (STabilisation of Atherosclerotic plaque By Initiation of darapLadIb TherapY) Trial and ACC Wrap-up from the Pacific Rim Perspective
- Embargo Lift: Sunday, March 30, 2014 at 8:00am
Tuesday, April 1, 2014
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
9:00 AM - 9:30 AM *TCTMD Studio Not Available
- Interviewee: Dr. Sigmund Silber
- Topic: ACC Wrap Up in German
9:30 AM
OPEN TIME SLOT
10:00 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT